163 related articles for article (PubMed ID: 2783356)
1. Immunization after invasive Haemophilus influenzae type b disease. Serologic response to a conjugate vaccine.
Edwards KM; Decker MD; Porch CR; Palmer P; Bradley R
Am J Dis Child; 1989 Jan; 143(1):31-3. PubMed ID: 2783356
[TBL] [Abstract][Full Text] [Related]
2. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
Sood SK; Daum RS
Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children with sickle hemoglobinopathy or malignancies, and after systemic Haemophilus influenzae type b infection.
Kaplan SL; Duckett T; Mahoney DH; Kennedy LL; Dukes CM; Schaffer DM; Mason EO
J Pediatr; 1992 Mar; 120(3):367-70. PubMed ID: 1538281
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
Walter EB; Moggio MV; Drucker RP; Wilfert CM
Pediatr Infect Dis J; 1990 Sep; 9(9):632-5. PubMed ID: 2235187
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of the Haemophilus influenzae type b capsular polysaccharide conjugate vaccine in children after systemic Haemophilus influenzae type b infections.
Kaplan SL; Zahradnik JM; Mason EO; Dukes CM
J Pediatr; 1988 Aug; 113(2):272-7. PubMed ID: 3260943
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
Granoff DM; Chacko A; Lottenbach KR; Sheetz KE
J Pediatr; 1989 Jun; 114(6):925-33. PubMed ID: 2786062
[TBL] [Abstract][Full Text] [Related]
7. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate).
Gray BM
Pediatrics; 1990 Apr; 85(4 Pt 2):694-7. PubMed ID: 2107521
[TBL] [Abstract][Full Text] [Related]
8. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
Rothstein EP; Schiller RP; Girone JA; Hipp TJ; Souder RL; Bernstein HH; Madore DV; Johnson CL; Smith DH
Am J Dis Child; 1991 Aug; 145(8):898-900. PubMed ID: 1858727
[TBL] [Abstract][Full Text] [Related]
9. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B; Wald E; Guerra N; Byers C
Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
[TBL] [Abstract][Full Text] [Related]
10. Anti-polyribosylribitol phosphate antibody in pediatric patients with Haemophilus influenzae type b invasive disease.
Ishiwada N; Honda Y; Tanaka J; Hishiki H; Kohno Y
J Infect Chemother; 2011 Jun; 17(3):397-400. PubMed ID: 21188446
[TBL] [Abstract][Full Text] [Related]
11. Responses of children to booster immunization with their primary conjugate Haemophilus influenzae type B vaccine or with polyribosylribitol phosphate conjugated with diphtheria toxoid.
Decker MD; Edwards KM; Bradley R; Palmer P
J Pediatr; 1993 Mar; 122(3):410-3. PubMed ID: 8441096
[TBL] [Abstract][Full Text] [Related]
12. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
[TBL] [Abstract][Full Text] [Related]
13. National Advisory Committee on Immunization (NACI). Statement on Haemophilus influenzae type B conjugate vaccines for use in infants and children.
Can Commun Dis Rep; 1992 Dec; 18(23):169-76. PubMed ID: 1291012
[TBL] [Abstract][Full Text] [Related]
14. IgG subclass response to immunization with Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine.
Granoff DM; Weinberg GA; Shackelford PG
Pediatr Res; 1988 Aug; 24(2):180-5. PubMed ID: 3263612
[TBL] [Abstract][Full Text] [Related]
15. Immunization with Haemophilus influenzae type b polysaccharide vaccine at 18 and 24 months of age: evidence of decreased immunogenicity.
Adderson EE; Chisholm N; Halperin SA
Clin Invest Med; 1991 Aug; 14(4):338-45. PubMed ID: 1782732
[TBL] [Abstract][Full Text] [Related]
16. Depression of anticapsular antibody after immunization with Haemophilus influenzae type b polysaccharide-diphtheria conjugate vaccine.
Marchant CD; Band E; Froeschle JE; McVerry PH
Pediatr Infect Dis J; 1989 Aug; 8(8):508-11. PubMed ID: 2788860
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
Mäkelä PH; Eskola J; Peltola H; Takala AK; Käyhty H
Pediatrics; 1990 Apr; 85(4 Pt 2):651-3. PubMed ID: 2179855
[TBL] [Abstract][Full Text] [Related]
18. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
[TBL] [Abstract][Full Text] [Related]
19. Antibody response to immunization with Haemophilus influenzae type b polysaccharide vaccine in children with cancer.
Weisman SJ; Cates KL; Allegretta GJ; Quinn JJ; Altman AJ
J Pediatr; 1987 Nov; 111(5):727-9. PubMed ID: 3499501
[No Abstract] [Full Text] [Related]
20. Comparison of active and combined passive/active immunization of Navajo children against Haemophilus influenzae type b.
Letson GW; Santosham M; Reid R; Priehs C; Burns B; Jahnke A; Gahagan S; Nienstadt L; Johnson C; Smith D
Pediatr Infect Dis J; 1988 Nov; 7(11):747-52. PubMed ID: 3266005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
